Therapeutic Exposures of CX-8998, a Potent, Selective and State-Dependent Cav3 Channel Antagonist with Dose-Dependent Efficacy in Cav3-Driven Neurological Models

Lee, M; Papapetropoulos, S; Newbold, E

NEUROTHERAPEUTICS, 2018; 15 (3): 830